2026年06月23日　星期二 [关闭窗口]    
请稍候...
 宜宾市第二人民医院  文献交流　

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial 　

上一条  发布日期：2022-03-21　09:32:26　点击次数：1015   下一条

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trialSemaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trialSemaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial

[本条信息由 胃肠疝外科 上传]
上一条：Laparoscopic versus open transverse-incision right hemicolectomy: a retrospective comparison study下一条：Role of transanal irrigation in the treatment of anterior resection syndrome